Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT
· Real-Time Price · USD
22.57
1.37 (6.46%)
At close: Jul 02, 2025, 3:59 PM
22.54
-0.16%
After-hours: Jul 02, 2025, 07:57 PM EDT
6.46% (1D)
| Bid | 20.79 |
| Market Cap | 16.77B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -240.75M |
| EPS (ttm) | -0.34 |
| PE Ratio (ttm) | -66.4 |
| Forward PE | -49.47 |
| Analyst | Buy |
| Ask | 23.78 |
| Volume | 2,305,752 |
| Avg. Volume (20D) | 5,059,255 |
| Open | 21.24 |
| Previous Close | 21.20 |
| Day's Range | 21.17 - 22.84 |
| 52-Week Range | 6.78 - 36.91 |
| Beta | -1.05 |
About SMMT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SMMT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SMMT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts21 hours ago
+6.7%
Summit Therapeutics shares are trading higher on p...
Unlock content with
Pro Subscription
1 month ago
-30.48%
Summit Therapeutics shares are trading lower. The company announced topline results from its Phase 3 HARMONi trial.
